In last trading session, Zura Bio Ltd (NASDAQ:ZURA) saw 0.39 million shares changing hands with its beta currently measuring 0.20. Company’s recent per share price level of $1.28 trading at $0.2 or 18.52% at ring of the bell on the day assigns it a market valuation of $83.58M. That closing price of ZURA’s stock is at a discount of -396.09% from its 52-week high price of $6.35 and is indicating a premium of 16.41% from its 52-week low price of $1.07. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.24 million shares which gives us an average trading volume of 454.94K if we extend that period to 3-months.
For Zura Bio Ltd (ZURA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.25. Splitting up the data highlights that, out of 11 analysts covering the stock, 0 rated the stock as a Sell while 1 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 8 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of 0 in the current quarter.
Zura Bio Ltd (NASDAQ:ZURA) trade information
Upright in the green during last session for gaining 18.52%, in the last five days ZURA remained trading in the green while hitting it’s week-highest on Monday, 03/10/25 when the stock touched $1.28 price level, adding 1.53% to its value on the day. Zura Bio Ltd’s shares saw a change of -48.80% in year-to-date performance and have moved 1.59% in past 5-day. Zura Bio Ltd (NASDAQ:ZURA) showed a performance of -9.22% in past 30-days. Number of shares sold short was 5.23 million shares which calculate 12.41 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 15 to the stock, which implies a rise of 91.47% to its current value. Analysts have been projecting 15 as a low price target for the stock while placing it at a high target of 15. It follows that stock’s current price would drop -1071.88% in reaching the projected high whereas dropping to the targeted low would mean a loss of -1071.88% for stock’s current value.
In 2025, company’s earnings growth rate is likely to be around 68.12% while estimates for its earnings growth in next 5 years are of 24.30%.
Zura Bio Ltd (NASDAQ:ZURA)’s Major holders
Insiders are in possession of 31.87% of company’s total shares while institution are holding 62.79 percent of that, with stock having share float percentage of 92.16%. Investors also watch the number of corporate investors in a company very closely, which is 62.79% institutions for Zura Bio Ltd that are currently holding shares of the company.
On the other hand, iShares Russell 2000 ETF and Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 1.2 shares of worth $1.54 million or 1.84% of the total outstanding shares. The later fund manager was in possession of 500.32 shares on Dec 31, 2024 , making its stake of worth around $0.64 million in the company or a holder of 0.77% of company’s stock.
